Condition 1: Endometriosis. Condition 2: Repeated implantation failure. Endometriosis Female infertility of uterine origin
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving prednisolone, take 10 mg of prednisolone tablets manufactured by Abu Raihan Company daily.The duration of the intake is from one month before emb
Sponsors
Iranian academic center for education culture and research
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Women with endometriosis and recurrent implantation failure History of at least two failed grade A embryo or blastocyst transfers Having a frozen Grade A embryo or blastocyst Age under 40 years
Exclusion criteria
Exclusion criteria: Specific causes of implantation failure include: anatomic, chromosomal, untreated hydrosalpinx, and chronic endometritis. Immunological cause of implantation failure, such as autoantibodies or immunological diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy. Timepoint: Six weeks after embryo transfer. Method of measurement: Observing the fetal heartbeat on a 6-week transvaginal ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Implantation success rate. Timepoint: Two weeks after the embryo transfer. Method of measurement: Measurement of serum levels of beta human chorionic gonadotropin (Beta-hCG). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Tavakoli
Iranian academic center for education culture and research
Outcome results
None listed